Subcutaneous lipoatrophy induced by long-term pegvisomant administration.
Salvatore
Cannavo
C
Giovanni
Romanello
R
Vittorio
Cavallari
C
Claudio
Scisca
S
Patrizia
Cannavo Serafinella
CS
D000172:Acromegaly / Q000188:drug therapy; D000328:Adult; D001284:Atrophy / Q000139:chemically induced / Q000175:diagnosis / Q000473:pathology; D004305:Dose-Response Relationship, Drug; D005260:Female; D019382:Human Growth Hormone / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D008060:Lipodystrophy / Q000139:chemically induced* / Q000175:diagnosis / Q000473:pathology*; D050151:Subcutaneous Fat / Q000473:pathology*
D019382:Human Growth Hormone; C406545:pegvisomant